These warning letters, however, pave no new ground, but should still be reviewed and understood by describing regulatory violations which companies are well advised to avoid.
Peptides are not ready to use
The relevant research question is whether intracellular NNMT inhibition produces pathway-specific effects under defined laboratory conditions, or whether broader changes in nicotinamide metabolism, NAD + availability, SAM-dependent methylation balance, and related biochemical pathways may influence additional cellular systems
In animal studies, peptide exposure was linked with increased fibroblast activity, suggesting potential roles in connective tissue processes
Shiv Goel is a triple board-certified physician in Internal, Functional, and Aesthetic Medicine Mount Sinai-trained, formerly Medical Director at Methodist Hospital San Antonio, and an IFBB Masters Champion who lives the work he prescribes